S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Leading Egyptian opposition politician targeted with spyware, researchers find
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Leading Egyptian opposition politician targeted with spyware, researchers find
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Leading Egyptian opposition politician targeted with spyware, researchers find
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Leading Egyptian opposition politician targeted with spyware, researchers find
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
NASDAQ:QDEL

QuidelOrtho (QDEL) Stock Forecast, Price & News

$71.63
-0.19 (-0.26%)
(As of 09/22/2023 ET)
Compare
Today's Range
$71.62
$72.56
50-Day Range
$71.63
$88.63
52-Week Range
$66.88
$102.00
Volume
396,990 shs
Average Volume
558,472 shs
Market Capitalization
$4.78 billion
P/E Ratio
108.53
Dividend Yield
N/A
Price Target
$119.83

QuidelOrtho MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
67.3% Upside
$119.83 Price Target
Short Interest
Healthy
3.71% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-2.61
Upright™ Environmental Score
News Sentiment
0.39mentions of QuidelOrtho in the last 14 days
Based on 9 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
9.07%
From $4.96 to $5.41 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.64 out of 5 stars

Medical Sector

76th out of 965 stocks

Diagnostic Substances Industry

1st out of 12 stocks


QDEL stock logo

About QuidelOrtho (NASDAQ:QDEL) Stock

QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies and solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was founded in 1979 and is headquartered in San Diego, California.

QDEL Price History

QDEL Stock News Headlines

Should You Add QuidelOrtho (QDEL) to Your Portfolio?
WARNING: Mandatory U.S. Dollar Recall is Weeks Away
If you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.
Where QuidelOrtho Stands With Analysts
This Stock Could Go Up 66% or More.
Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023.  Click here to get his latest buy.  More here.
Craig-Hallum Keeps Their Buy Rating on QuidelOrtho (QDEL)
QuidelOrtho: A Tough Call To Make Right Now
QuidelOrtho Corp.
See More Headlines
Receive QDEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for QuidelOrtho and its competitors with MarketBeat's FREE daily newsletter.

QDEL Company Calendar

Last Earnings
8/08/2023
Today
9/24/2023
Next Earnings (Estimated)
11/01/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Diagnostic substances
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:QDEL
CUSIP
74838J10
Employees
7,000
Year Founded
1979

Price Target and Rating

Average Stock Price Forecast
$119.83
High Stock Price Forecast
$173.00
Low Stock Price Forecast
$85.00
Forecasted Upside/Downside
+67.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Net Income
$548.70 million
Pretax Margin
2.15%

Debt

Sales & Book Value

Annual Sales
$3.27 billion
Cash Flow
$18.23 per share
Book Value
$74.71 per share

Miscellaneous

Free Float
64,988,000
Market Cap
$4.78 billion
Optionable
Optionable
Beta
0.27

Social Links

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Douglas C. BryantMr. Douglas C. Bryant (Age 65)
    Pres, CEO & Director
    Comp: $4.82M
  • Mr. Joseph M. Busky CPA (Age 55)
    Chief Financial Officer
    Comp: $1.47M
  • Mr. Robert J. Bujarski J.D. (Age 54)
    Exec. VP & COO
    Comp: $2.62M
  • Ms. Michelle A. Hodges (Age 63)
    Sr. VP & Gen. Counsel
    Comp: $1.8M
  • Dr. Werner Kroll Ph.D. (Age 66)
    Sr. VP of R&D
    Comp: $1.25M
  • Ms. Louise M. Brandy
    Sr. VP & Chief Information Officer
  • Mr. Patrick E. Klein
    Chief Admin. Officer
  • Ruben Argueta
    Director of Investor Relations
  • Mr. William J. FerenczyMr. William J. Ferenczy (Age 67)
    Point of Care Bus. Unit Leader
  • Mr. Michael S. Iskra (Age 53)
    Exec. VP & Chief Commercial Officer













QDEL Stock - Frequently Asked Questions

Should I buy or sell QuidelOrtho stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for QuidelOrtho in the last year. There are currently 2 hold ratings, 2 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" QDEL shares.
View QDEL analyst ratings
or view top-rated stocks.

What is QuidelOrtho's stock price forecast for 2023?

5 Wall Street research analysts have issued 1-year price objectives for QuidelOrtho's shares. Their QDEL share price forecasts range from $85.00 to $173.00. On average, they predict the company's stock price to reach $119.83 in the next twelve months. This suggests a possible upside of 67.3% from the stock's current price.
View analysts price targets for QDEL
or view top-rated stocks among Wall Street analysts.

How have QDEL shares performed in 2023?

QuidelOrtho's stock was trading at $85.67 at the start of the year. Since then, QDEL stock has decreased by 16.4% and is now trading at $71.63.
View the best growth stocks for 2023 here
.

When is QuidelOrtho's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 1st 2023.
View our QDEL earnings forecast
.

How were QuidelOrtho's earnings last quarter?

QuidelOrtho Co. (NASDAQ:QDEL) released its quarterly earnings results on Tuesday, August, 8th. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.03. The company earned $665.10 million during the quarter, compared to the consensus estimate of $615.11 million. QuidelOrtho had a net margin of 1.43% and a trailing twelve-month return on equity of 7.65%. The company's revenue was up 8.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.11 EPS.

What guidance has QuidelOrtho issued on next quarter's earnings?

QuidelOrtho updated its FY 2023 earnings guidance on Wednesday, August, 9th. The company provided EPS guidance of $4.85-$5.30 for the period, compared to the consensus estimate of $5.34. The company issued revenue guidance of $2.88 billion-$3.08 billion, compared to the consensus revenue estimate of $3.00 billion.

What is Doug Bryant's approval rating as QuidelOrtho's CEO?

47 employees have rated QuidelOrtho Chief Executive Officer Doug Bryant on Glassdoor.com. Doug Bryant has an approval rating of 76% among the company's employees.

What other stocks do shareholders of QuidelOrtho own?

Based on aggregate information from My MarketBeat watchlists, some companies that other QuidelOrtho investors own include NVIDIA (NVDA), DocuSign (DOCU), Tesla (TSLA), PayPal (PYPL), Shopify (SHOP), Block (SQ), Teladoc Health (TDOC), Netflix (NFLX), Advanced Micro Devices (AMD) and Zoom Video Communications (ZM).

What is QuidelOrtho's stock symbol?

QuidelOrtho trades on the NASDAQ under the ticker symbol "QDEL."

Who are QuidelOrtho's major shareholders?

QuidelOrtho's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.50%), ArrowMark Colorado Holdings LLC (4.83%), Senvest Management LLC (4.65%), State Street Corp (2.33%), JPMorgan Chase & Co. (1.79%) and Geode Capital Management LLC (1.27%). Insiders that own company stock include Charles P Slacik, Douglas C Bryant, Mary Lake Ph D Polan, Werner Kroll, William J Ferenczy and William J Ferenczy.
View institutional ownership trends
.

How do I buy shares of QuidelOrtho?

Shares of QDEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is QuidelOrtho's stock price today?

One share of QDEL stock can currently be purchased for approximately $71.63.

How much money does QuidelOrtho make?

QuidelOrtho (NASDAQ:QDEL) has a market capitalization of $4.78 billion and generates $3.27 billion in revenue each year. The company earns $548.70 million in net income (profit) each year or $0.66 on an earnings per share basis.

How many employees does QuidelOrtho have?

The company employs 7,000 workers across the globe.

How can I contact QuidelOrtho?

QuidelOrtho's mailing address is 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA, 92121. The official website for the company is www.quidel.com. The company can be reached via phone at (800) 874-1517, via email at rargueta@quidel.com, or via fax at 858-453-4338.

This page (NASDAQ:QDEL) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -